Table 3 Incidence and distribution of immunomarkers along with comparative percentages
From: A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon
Immuno-marker | Number of performed tests | Positive | Negative | ||||
|---|---|---|---|---|---|---|---|
Count | AGCT | JGCT | Count | AGCT | JGCT | ||
Inhibine | 40 | 30 (75%) | 27 (90%) | 3 (10%) | 10 (25%) | 8 (80%) | 2 (20%) |
Calretinin | 23 | 18 (78.3%) | 16 (88.9%) | 2 (11.1%) | 5 (21.7%) | 5 (100%) | 0 (0%) |
Cytokeratin | 20 | 10 (50%) | 9 (90%) | 1 (10%) | 10 (50%) | 9 (90%) | 1 (1%) |
CD99 | 23 | 19 (82.6%) | 17 (89.5%) | 2 (10.5%) | 4 (17.4%) | 4 (100%) | 0 (0%) |
Vimentin | 18 | 18 (100%) | 16 (88.9%) | 2 (11.1%) | 0 (0%) | 0 (0%) | 0 (0%) |